ATB Therapeutics

Biotech · Private

Weaponized antibody platform for oncology and immunology

atbtherapeutics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
4
0 granted · 4 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3129MABSWITCH, INC.——
3130KINEA BIO, INC.——
3131nChroma Bio——
3132ATB Therapeutics——
3133Flux Therapeutics, LLC——
3134Engrail Therapeutics——
3135PHAGEPRO, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 4
  • Humanized Antibodies Against CD79Bapplication
  • Recombinant Immunotoxin Comprising A Ribosome Inactivating Proteinapplication
  • Recombinant Immunotoxin Comprising A Ribotoxin Or Rnaseapplication
  • Method Of Producing An Uncleaved Cleavable Binder-toxin Protein In A Plant Cell Or A Whole Plantapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.